RecruitingNCT04361994

The GErman Italian Spanish Takotsubo (GEIST) Registry

Sponsor

Prof. Dr. med. Ingo Eitel

Enrollment

500 participants

Start Date

Apr 1, 2015

Study Type

OBSERVATIONAL

Conditions

Takotsubo Syndrome

Summary

GEIST is a multicenter, international observational registry of patients with Takotsubo syndrome. Data regarding the clinical profile (demographic characteristics, clinical presentation, laboratory measures, electrocardiography /echocardiography / coronary angiography parameters, treatment and medication), in-hospital course and complications and short-/long-term outcome are collected prospectively and retrospectively to increase the understanding of the disease.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with takotsubo syndrome. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(2)

Universität zu Lübeck

Lübeck, Schleswig-Holstein, Germany

University of Foggia

Foggia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04361994

Related Trials

Mechanisms And Prognosis of Stroke-Heart Syndrome

NCT069541031 location

BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.

NCT0466645416 locations